Results 191 to 200 of about 29,710 (291)

Exacerbated Hepatic Stress and Systemic Metabolic Disruption Driven by SARS‐CoV‐2 P.1 Variant in K18‐hACE2 Mice

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 6, June 2026.
ABSTRACT Introduction While severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been extensively studied in the context of pulmonary disease, its impact on metabolic organs remains poorly understood, particularly across experimental models.
Monara Kaélle Sérvulo Cruz Angelim   +9 more
wiley   +1 more source

Feline diabetes. Part 2: monitoring and management with other diseases

open access: yesIn Practice, Volume 48, Issue 5, Page 228-241, June 2026.
Background: Diabetes mellitus (DM) in cats is commonly seen in primary care practice and presents several clinical and practical challenges to owners and vets. In recent years feline DM has seen paradigm shifts in management and monitoring. Aim of the article: In this second article of a series on feline DM, we look at the monitoring options that are ...
Ian Ramsey, Anna Kraemer
wiley   +1 more source

Knowledge, competence, experience of healthcare practitioners using glucometers for patient care in Nigeria. [PDF]

open access: yesAfr J Lab Med
Muazu SB   +9 more
europepmc   +1 more source

Spinal Implant–Associated Infection in Type 2 and Type 1 Diabetes: Phenotype‐Specific Inflammatory Features and Therapeutic Response to Semaglutide

open access: yesJOR SPINE, Volume 9, Issue 2, June 2026.
ABSTRACT Background Diabetes mellitus (DM) is a major risk factor for postoperative infection and wound complications in spine surgery, yet distinctions between Type 2 (T2DM) and Type 1 (T1DM) pathophysiology are rarely addressed. This study compares infectious burden, wound healing, and immune response among a murine model of spinal implant‐associated
Thomas E. Olson   +16 more
wiley   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 42, Issue 6, June 2026.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao   +7 more
wiley   +1 more source

The Plasma Free Fatty Acid Carrier Proteome is Altered in Diet‐Induced and Genetically Obese Mice

open access: yesObesity, Volume 34, Issue 6, Page 1300-1313, June 2026.
ABSTRACT Objective We aimed to examine the effect of obesity on the plasma free fatty acid (FFA) carrier proteome in mice. Methods From 6 to 20 weeks of age, male and female C57BL/6J wild‐type mice were fed either a low‐fat diet (10% of kilocalories from fat) or a high‐fat diet (60% of kilocalories from fat), and leptin‐deficient ob/ob mice were fed a ...
Keigo Tomoo   +3 more
wiley   +1 more source

Poor glycemic control and its associated factors among type 1 diabetic children in Ethiopia: a systematic review and meta-analysis. [PDF]

open access: yesBMC Public Health
Meseret F   +6 more
europepmc   +1 more source

Morphological and Biochemical Insights Into the Renoprotective Effects of Combined N‐Acetylcysteine and Glycine Treatment in Experimental Diabetic Nephropathy

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and the leading cause of end‐stage renal disease. Oxidative stress and inflammation are central drivers of DN progression, yet no effective therapies exist to prevent or delay renal injury. This study investigated the renoprotective effects of glycine (GLY), N‐
Malik Ejubović   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy